TRIB3 and non-small cell lung carcinoma: Knocking down of TRIB3 inhibited tumor growth, metastasis, and increased the survival rate of tumor-bearing mice in NSCLC PDX and A549 xenograft models (Fig. 8l, m and Supplementary Fig. 8a–c), confirming the tumor-promotion role of TRIB3 in NSCLC.